logo
  • Home
  • Company
  • BRS-HIVEC™
    • BRS System
    • BRS Kit
    • Clinical information
    • BRS-HIVEC™ Trials
    • BRS-HIVEC™ Centres
    • Published Data
  • PRS-HIPEC
    • Clinical Information
    • HIPEC Trials
    • HIPEC Centres
    • Published Data
  • Healthcare Professionals
  • Partners
    • Investors
    • Distributors
  • Patient Area
    • Bladder Cancer – EN
    • Bladder Cancer – DE
    • Peritoneal Cancers
  • News
  • Contact

Recent Posts

To keep most up to date with news about COMBAT Medical:-

The Combat team are exhibiting on stand I10 at EAU 2019

Wishing you all a Merry Christmas and all the best for 2019

BAUS Oncology at York Exhibition Centre on the 6th and 7th of December – Stand 2

Combat Medical shortlisted in The Telegraph Trade Awards 2018-Best New Entrant into International Markets 2018

CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
6 Nov 1324669832218988546

👏🏻👏🏻👏🏻

Alvaro Arjona@alarjosan

El Hospital Reina Sofía coordina un macroestudio que pretende prevenir la metástasis del cáncer de colon. @HUReinaSofia @Hospital_FJD @CirugiaHugc @SeguraJuanJ @aecirujanos https://www.lavanguardia.com/local/sevilla/20180226/441108275675/el-hospital-reina-sofia-coordina-un-macroestudio-que-pretende-prevenir-la-metastasis-del-cancer-de-colon.html

Reply on Twitter 1324669832218988546Retweet on Twitter 13246698322189885462Like on Twitter 13246698322189885466Twitter 1324669832218988546
Retweet on TwitterCombat Medical #HIVEC #HIPEC Retweeted
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
5 Nov 1324321513265397760

Yet another publication showing #HIVEC to be a viable, safe and well tolerated treatment for BCG failure patients with both #mitomycin and #epirubicin.
Thanks to @francescok86 for his great work.
#BladderCancer #Hyperthermia #BCG
https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/125687-outcomes-and-complications-of-hyperthermic-intravesical-chemotherapy-using-mitomycin-c-or-epirubicin-for-patients-with-non-muscle-invasive-bladder-cancer-after-bacillus-calmette-guerin-treatment-failure.html

Twitter feed video.
Image for the Tweet beginning: Yet another publication showing #HIVEC
Reply on Twitter 1324321513265397760Retweet on Twitter 13243215132653977605Like on Twitter 132432151326539776010Twitter 1324321513265397760
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
5 Nov 1324321513265397760

Yet another publication showing #HIVEC to be a viable, safe and well tolerated treatment for BCG failure patients with both #mitomycin and #epirubicin.
Thanks to @francescok86 for his great work.
#BladderCancer #Hyperthermia #BCG
https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/125687-outcomes-and-complications-of-hyperthermic-intravesical-chemotherapy-using-mitomycin-c-or-epirubicin-for-patients-with-non-muscle-invasive-bladder-cancer-after-bacillus-calmette-guerin-treatment-failure.html

Twitter feed video.
Image for the Tweet beginning: Yet another publication showing #HIVEC
Reply on Twitter 1324321513265397760Retweet on Twitter 13243215132653977605Like on Twitter 132432151326539776010Twitter 1324321513265397760
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
2 Nov 1323270147436613633

Thank you @AldousSteve

Steve Aldous@AldousSteve

Huge congratulations to @CombatCancer for reaching 400 followers on @Twitter . Well done everybody!! #Hivec #Hipec #CombatCancer

Reply on Twitter 1323270147436613633Retweet on Twitter 13232701474366136331Like on Twitter 13232701474366136332Twitter 1323270147436613633
Retweet on TwitterCombat Medical #HIVEC #HIPEC Retweeted
ESSOnews avatarEuropean Society of Surgical Oncology (ESSO)@ESSOnews·
21 Oct 1318895917983010819

📢NEXT WEEK📢Prophylactic #peritoneal Management of High-Risk #ColonCancer

🗓️3 NOV-18.30 CEST

🗣Dr @AndreasBrandl8, Dr @alarjosan, Dr Diane Goéré & Dr Pieter Tanis ➡️https://lnkd.in/gNsACYN

#HIPEC #PeritonealMetastases #colorectalsurgery #colorectalcancer @CombatCancer

Twitter feed video.
Image for the Tweet beginning: 📢NEXT WEEK📢Prophylactic #peritoneal Management of
Reply on Twitter 1318895917983010819Retweet on Twitter 13188959179830108199Like on Twitter 131889591798301081918Twitter 1318895917983010819
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
12 Oct 1315675470365708288

They don’t do an emoji for HIPEC with agitation bubbles of CO2.
Is this close enough @alarjosan?
🛁🛁🛁🛁🛁

Reply on Twitter 1315675470365708288Retweet on Twitter 13156754703657082881Like on Twitter 13156754703657082886Twitter 1315675470365708288
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
12 Oct 1315675088771903488

Laparoscopic cytoreductive surgery and HIPEC for a limited low-grade pseudomyxoma peritonei.
Performed by Dr @alarjosan and team at @HUReinaSofia
👏🏻👏🏻👏🏻👏🏻

Twitter feed video.
Reply on Twitter 1315675088771903488Retweet on Twitter 13156750887719034883Like on Twitter 131567508877190348811Twitter 1315675088771903488
Retweet on TwitterCombat Medical #HIVEC #HIPEC Retweeted
ESSOnews avatarEuropean Society of Surgical Oncology (ESSO)@ESSOnews·
8 Oct 1314152834707976192

📢Webinar Alert📢
Prophylactic #peritoneal Management of High-Risk #ColonCancer

🗓️3 November-18.30 CEST

🗣Dr @AndreasBrandl8, Dr Alvaro-Arjona-Sanchez, Dr Diane Goéré & Dr Pieter Tanis

👉https://www.essoweb.org/courses/

#HIPEC #PeritonealMetastases #colorectalsurgery #colorectalcancer

Twitter feed video.
Image for the Tweet beginning: 📢Webinar Alert📢
Prophylactic #peritoneal Management of
Reply on Twitter 1314152834707976192Retweet on Twitter 131415283470797619211Like on Twitter 131415283470797619221Twitter 1314152834707976192
Retweet on TwitterCombat Medical #HIVEC #HIPEC Retweeted
OxfordTechVC avatarOxford Technology@OxfordTechVC·
2 Sep 1301182775819722759

Three of our portfolio companies (@CombatCancer @LightpointMed
and @entiahealth) named by Coutts as "#medtech marvels supporting the NHS"

Coutts backs med-tech marvels supporting NHS

Meet four of the firms forging the future of health care with help from our clients

www.coutts.com

Reply on Twitter 1301182775819722759Retweet on Twitter 13011827758197227593Like on Twitter 13011827758197227594Twitter 1301182775819722759
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
3 Sep 1301399440574554112


To register for this Friday's webinar (5-6 UK) click on the Eventbrite link
#HIVEC #BCGUnresponsive

HIVEC for BCG Unresponsive

Find out more about HIVEC in BCG Unresponsive Patients with Clinical Discussion and Live Q&A. EAU20 Presented Data.

www.eventbrite.co.uk

Reply on Twitter 1301399440574554112Retweet on Twitter 13013994405745541122Like on Twitter 13013994405745541123Twitter 1301399440574554112
Retweet on TwitterCombat Medical #HIVEC #HIPEC Retweeted
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
10 Aug 1292795870858158080

Join us on Friday 4th September at 5pm to find out more about HIVEC in BCG Unresponsive patients

Twitter feed video.
Image for the Tweet beginning: Join us on Friday 4th
Reply on Twitter 1292795870858158080Retweet on Twitter 12927958708581580802Like on Twitter 12927958708581580802Twitter 1292795870858158080
Retweet on TwitterCombat Medical #HIVEC #HIPEC Retweeted
alarjosan avatarAlvaro Arjona@alarjosan·
27 Aug 1299077932841873408

@cordekroon @HUReinaSofia @ESSOnews @operarelcancer @SWexner @DeliaCortesGuir @FarazKh65499316 @dr_mohammadyami @AndreasBrandl8 @annafagottimd Closed system with CO2 agitation system @CombatCancer @jansenaxel is an option for drug distribution

Reply on Twitter 1299077932841873408Retweet on Twitter 12990779328418734082Like on Twitter 12990779328418734083Twitter 1299077932841873408
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
10 Aug 1292795870858158080

Join us on Friday 4th September at 5pm to find out more about HIVEC in BCG Unresponsive patients

Twitter feed video.
Image for the Tweet beginning: Join us on Friday 4th
Reply on Twitter 1292795870858158080Retweet on Twitter 12927958708581580802Like on Twitter 12927958708581580802Twitter 1292795870858158080
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
20 Jul 1285178063626567680

#HIVEC #EAU20 Data presented at EAU20 shows HIVEC treated BCG unresponsive patients 54% RFS at 24 months. Complete Response Rate for BCG unresponsive CIS patients over 70% at 6 months. Contact us to find out more.

Twitter feed video.
Image for the Tweet beginning: #HIVEC #EAU20 Data presented at
Reply on Twitter 1285178063626567680Retweet on Twitter 12851780636265676802Like on Twitter 12851780636265676809Twitter 1285178063626567680
CombatCancer avatarCombat Medical #HIVEC #HIPEC@CombatCancer·
10 Jul 1281603968020500482

Just in case you missed this trial data presented at AUA20, #HIVEC immediately prior to TURBT shows equivalent recurrence to I-POP but with 100% adherence for HIVEC, 33% greater than for I-POP.https://bit.ly/3fjnHyD

Twitter feed video.
Image for the Tweet beginning: Just in case you missed
Reply on Twitter 1281603968020500482Retweet on Twitter 12816039680205004821Like on Twitter 12816039680205004824Twitter 1281603968020500482
Load More...

Wishing you all a Merry Christmas and all the best for 2019

by Combat | on19 December 2018 | Distributors, Events, Investors, News, Partners, PR | No Comments

 

For more information contact: Combat Medical Ltd. Lamer House Office, Lamer Lane, Wheathampstead, Hertfordshire, AL4 8RL
Tel/Fax: +44 1582 83 44 66 Email: contact@combat-medical.com
Privacy Statement
This site uses cookies: Find out more.
Combat Medical

Welcome.

Please select your region.

United Kingdom
Europe
United States